P1570: SARS‐COV‐2 HUMORAL AND CELLULAR VACCINATION RESPONSE IN PATIENTS WITH LYMPHOID HAEMATOLOGICAL MALIGNANCIES by Boerenkamp, L. S., Pothast, C. R., Dijkland, R. C., Loo, I. H., Wieten, L., Halkes, C. J., Heemskerk, M. H., Van Elssen, C. H.

Get full text

Increased Tumor-Specific CD8+ T Cell Induction by Dendritic Cells Matured with a Clinical Grade TLR-Agonist in Combination with IFN-γ by Vanderlocht, J., Van Elssen, C.H.M.J., Senden-Gijsbers, B.L.M.G., Meek, B., Cloosen, S., Libon, C., Bos, G.M.J., Germeraad, W.T.V.

Request full text

Increased CD8 T‐cell immunity after COVID‐19 vaccination in lymphoid malignancy patients lacking adequate humoral response: An immune compensation mechanism? by Boerenkamp, Lara S., Pothast, Cilia R., Dijkland, Romy C., Dijk, Kayleigh, Gorkom, Gwendolyn N. Y., Loo, Inge H. M., Wieten, Lotte, Halkes, Constantijn J. M., Heemskerk, Mirjam H. M., Van Elssen, Catharina H. M. J.

Get full text

A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer by Brandão, Rita D, Veeck, Jürgen, Van de Vijver, Koen K, Lindsey, Patrick, de Vries, Bart, van Elssen, Catharina H M J, Blok, Marinus J, Keymeulen, Kristien, Ayoubi, Torik, Smeets, Hubert J M, Tjan-Heijnen, Vivianne C, Hupperets, Pierre S

Get full text

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial by Löwenberg, Bob, Pabst, Thomas, Maertens, Johan, Gradowska, Patrycja, Biemond, Bart J., Spertini, Olivier, Vellenga, Edo, Griskevicius, Laimonas, Tick, Lidwine W., Jongen-Lavrencic, Mojca, van Marwijk Kooy, Marinus, Vekemans, Marie-Christiane, van der Velden, Walter J.F.M., Beverloo, Berna, Michaux, Lucienne, Graux, Carlos, Deeren, Dries, de Weerdt, Okke, van Esser, Joost W.J., Bargetzi, Mario, Klein, Saskia K., Gadisseur, Alain, Westerweel, Peter E., Veelken, Hendrik, Gregor, Michael, Silzle, Tobias, van Lammeren-Venema, Daniëlle, Moors, Ine, Breems, Dimitri A., Hoogendoorn, Mels, Legdeur, Marie-Cecile J.C., Fischer, Thomas, Kuball, Juergen, Cornelissen, Jan, Porkka, Kimmo, Juliusson, Gunnar, Meyer, Peter, Höglund, Martin, Gjertsen, Bjorn T., Janssen, Jeroen J.W.M., Huls, Gerwin, Passweg, Jakob, Cloos, Jacqueline, Valk, Peter J.M., van Elssen, Catharina H.M.J., Manz, Markus G., Floisand, Yngvar, Ossenkoppele, Gert J.

Get full text

Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice by Frings, Peter W. H., Van Elssen, Catharina H. M. J., Wieten, Lotte, Matos, Catarina, Hupperets, Pierre S. J. G., Schouten, Harry C., Bos, Gerard M. J., van Gelder, Michel

Get full text

Klebsiella pneumoniae‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cells by Van Elssen, Catharina H.M.J, Vanderlocht, Joris, Frings, Peter W.H, Senden‐Gijsbers, Birgit L.M.G, Schnijderberg, Melanie C.A, van Gelder, Michel, Meek, Bob, Libon, Christine, Ferlazzo, Guido, Germeraad, Wilfred T.V, Bos, Gerard M.J

Get full text

In vitro–differentiated T/natural killer–cell progenitors derived from human CD34+ cells mature in the thymus by Meek, Bob, Cloosen, Silvie, Borsotti, Chiara, Van Elssen, Catharina H. M.J., Vanderlocht, Joris, Schnijderberg, Melanie C.A., van der Poel, Marjolein W.M., Leewis, Bas, Hesselink, Reinout, Manz, Markus G., Katsura, Yoshimoto, Kawamoto, Hiroshi, Germeraad, Wilfred T.V., Bos, Gerard M.J.

Get full text

T cells fail to develop in the human skin-cell explants system; an inconvenient truth by Meek, Bob, Van Elssen, Catharina H M J, Huijskens, Mirelle J A J, van der Stegen, Sjoukje J C, Tonnaer, Siebe, Lumeij, Stijn B J, Vanderlocht, Joris, Kirkland, Mark A, Hesselink, Reinout, Germeraad, Wilfred T V, Bos, Gerard M J

Get full text